S25-407 Genetically Encoded STING Agonists for Programmable Immune Activation in Cell Therapies Researchers at Stanford have developed genetically encoded STING agonists that enable controlled activation of the STING pathway from within engineered cells. Kyle Daniels Wansang Cho Michael Lim John Choi Annelise Barron